AAAAAA
Results:
1-23
|
Results: 23
Authors:
Lalonde, L
Clarke, AE
Joseph, L
Mackenzie, T
Grover, SA
Citation: L. Lalonde et al., Health-related quality of life with coronary heart disease prevention and treatment, J CLIN EPID, 54(10), 2001, pp. 1011-1018
Authors:
Grover, SA
Coupal, L
Zowall, H
Citation: Sa. Grover et al., How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease? Response to Egede, DIABET CARE, 24(7), 2001, pp. 1306-1307
Authors:
Grover, SA
Coupal, L
Zowall, H
Alexander, CM
Weiss, TW
Gomes, DRJ
Citation: Sa. Grover et al., How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?, DIABET CARE, 24(1), 2001, pp. 45-50
Authors:
White, PD
Thomas, JM
Kangro, HO
Bruce-Jones, WDA
Amess, J
Crawford, DH
Grover, SA
Clare, AW
Citation: Pd. White et al., Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis, LANCET, 358(9297), 2001, pp. 1946-1954
Authors:
Kahn, SR
Joseph, L
Grover, SA
Leclerc, JR
Citation: Sr. Kahn et al., A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep veinthrombosis, THROMB RES, 102(1), 2001, pp. 15-24
Authors:
Esdaile, JM
Abrahamowicz, M
Grodzicky, T
Li, Y
Panaritis, C
du Berger, R
Cote, R
Grover, SA
Fortin, PR
Clarke, AE
Senecal, JL
Citation: Jm. Esdaile et al., Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus, ARTH RHEUM, 44(10), 2001, pp. 2331-2337
Authors:
Grover, SA
Citation: Sa. Grover, Lipid management: what are the predictors of benefit?, EUR H J SUP, 2(L), 2000, pp. L2-L6
Authors:
McAlister, FA
O'Connor, AM
Wells, G
Grover, SA
Laupacis, A
Citation: Fa. Mcalister et al., When should hypertension be treated? The different perspectives of Canadian family physicians and patients, CAN MED A J, 163(4), 2000, pp. 403-408
Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines
Authors:
Grover, SA
Dorais, M
Paradis, G
Fodor, JG
Frohlich, JJ
McPherson, R
Coupal, L
Zowall, H
Citation: Sa. Grover et al., Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines, CAN MED A J, 163(10), 2000, pp. 1263-1269
Authors:
Grover, SA
Coupal, L
Zowall, H
Rajan, R
Trachtenberg, J
Elhilali, M
Chetner, M
Goldenberg, L
Citation: Sa. Grover et al., The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model, CAN MED A J, 162(7), 2000, pp. 977-983
Authors:
Grover, SA
Coupal, L
Zowall, H
Rajan, R
Trachtenberg, J
Elhilali, M
Chetner, M
Goldenberg, L
Citation: Sa. Grover et al., The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model, CAN MED A J, 162(7), 2000, pp. 987-992
Authors:
Grover, SA
Citation: Sa. Grover, Role of WHO-MONICA Project in unravelling of the cardiovascular puzzle, LANCET, 355(9205), 2000, pp. 668-669
Authors:
Grover, SA
Coupal, L
Zowall, H
Dorais, M
Citation: Sa. Grover et al., Cost-effectiveness of treating hyperlipidemia in the presence of diabetes - Who should be treated?, CIRCULATION, 102(7), 2000, pp. 722-727
Authors:
Lalonde, L
Clarke, AE
Joseph, L
Mackenzie, T
Grover, SA
Citation: L. Lalonde et al., Comparing the psychometric properties of preference-based and nonpreference-based health-related quality of life in coronary heart disease, QUAL LIFE R, 8(5), 1999, pp. 399-409
Authors:
Grover, SA
Levinton, C
Paquet, S
Citation: Sa. Grover et al., Identifying adults at low risk for significant hyperlipidemia: A validatedclinical index, J CLIN EPID, 52(1), 1999, pp. 49-55
Authors:
Perreault, S
Dorais, M
Coupal, L
Paradis, G
Joffres, MR
Grover, SA
Citation: S. Perreault et al., Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease. (vol 160, pg1449, 1999), CAN MED A J, 161(1), 1999, pp. 21-21
Authors:
Grover, SA
Citation: Sa. Grover, Estrogen replacement for women with cardiovascular disease: Why don't physicians and patients follow the guidelines?, CAN MED A J, 161(1), 1999, pp. 42-43
Authors:
Grover, SA
Zowall, H
Coupal, L
Krahn, MD
Citation: Sa. Grover et al., Prostate cancer: 12. The economic burden, CAN MED A J, 160(5), 1999, pp. 685-690
Authors:
Perreault, S
Dorais, M
Coupal, L
Paradis, G
Joffres, MR
Grover, SA
Citation: S. Perreault et al., Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease, CAN MED A J, 160(10), 1999, pp. 1449-1455
Authors:
Clarke, AE
Levinton, C
Joseph, L
Penrod, S
Zowall, H
Sibley, JT
Grover, SA
Esdaile, JM
Citation: Ae. Clarke et al., Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis, J RHEUMATOL, 26(5), 1999, pp. 1068-1075
Authors:
Lalonde, L
Clarke, AE
Joseph, L
Grover, SA
Citation: L. Lalonde et al., Conventional and chained standard gambles in the assessment of coronary heart disease prevention and treatment, MED DECIS M, 19(2), 1999, pp. 149-156
Authors:
Grover, SA
Coupal, L
Paquet, S
Zowall, H
Citation: Sa. Grover et al., Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease - Forecasting the incremental benefits of preventing coronary and cerebrovascular events, ARCH IN MED, 159(6), 1999, pp. 593-600
Authors:
White, PD
Thomas, JM
Amess, J
Crawford, DH
Grover, SA
Kangro, HO
Clare, AW
Citation: Pd. White et al., Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever, BR J PSYCHI, 173, 1998, pp. 475-481
Risultati:
1-23
|